These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 16112475)
21. Presynaptic localisation of the nicotinic acetylcholine receptor beta2 subunit immunoreactivity in rat nigrostriatal dopaminergic neurones. Jones IW; Bolam JP; Wonnacott S J Comp Neurol; 2001 Oct; 439(2):235-47. PubMed ID: 11596051 [TBL] [Abstract][Full Text] [Related]
22. From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease. Bellucci A; Zaltieri M; Navarria L; Grigoletto J; Missale C; Spano P Brain Res; 2012 Oct; 1476():183-202. PubMed ID: 22560500 [TBL] [Abstract][Full Text] [Related]
23. Identification of rotenone-induced modifications in alpha-synuclein using affinity pull-down and tandem mass spectrometry. Mirzaei H; Schieler JL; Rochet JC; Regnier F Anal Chem; 2006 Apr; 78(7):2422-31. PubMed ID: 16579629 [TBL] [Abstract][Full Text] [Related]
24. The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination. Herrera AJ; de Pablos RM; Carreño-Müller E; Villarán RF; Venero JL; Tomás-Camardiel M; Cano J; Machado A J Neurochem; 2008 May; 105(3):750-62. PubMed ID: 18179476 [TBL] [Abstract][Full Text] [Related]
25. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD. Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569 [TBL] [Abstract][Full Text] [Related]
26. Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease. Baloyannis SJ; Costa V; Baloyannis IS J Neurol Sci; 2006 Oct; 248(1-2):35-41. PubMed ID: 16753180 [TBL] [Abstract][Full Text] [Related]
27. Nigral burden of alpha-synuclein correlates with striatal dopamine deficit. Kovacs GG; Milenkovic IJ; Preusser M; Budka H Mov Disord; 2008 Aug; 23(11):1608-12. PubMed ID: 18649394 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of alpha-synuclein following methamphetamine: is it good or bad? Mauceli G; Busceti CI; Pellegrini A; Soldani P; Lenzi P; Paparelli A; Fornai F Ann N Y Acad Sci; 2006 Aug; 1074():191-7. PubMed ID: 17105917 [TBL] [Abstract][Full Text] [Related]
29. alpha-Synuclein expression in the brain and blood during abstinence from chronic alcohol drinking in mice. Ziolkowska B; Gieryk A; Wawrzczak-Bargiela A; Krowka T; Kaminska D; Korkosz A; Bienkowski P; Przewlocki R Neuropharmacology; 2008 Jun; 54(8):1239-46. PubMed ID: 18456291 [TBL] [Abstract][Full Text] [Related]
30. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model. Hayashita-Kinoh H; Yamada M; Yokota T; Mizuno Y; Mochizuki H Biochem Biophys Res Commun; 2006 Mar; 341(4):1088-95. PubMed ID: 16460685 [TBL] [Abstract][Full Text] [Related]
31. Differential messenger RNA expression of complexins in mouse brain. Freeman W; Morton AJ Brain Res Bull; 2004 Mar; 63(1):33-44. PubMed ID: 15121237 [TBL] [Abstract][Full Text] [Related]
32. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein. Yavich L; Oksman M; Tanila H; Kerokoski P; Hiltunen M; van Groen T; Puoliväli J; Männistö PT; García-Horsman A; MacDonald E; Beyreuther K; Hartmann T; Jäkälä P Neurobiol Dis; 2005 Nov; 20(2):303-13. PubMed ID: 16242637 [TBL] [Abstract][Full Text] [Related]
34. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions. Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575 [TBL] [Abstract][Full Text] [Related]
35. Dopamine innervation of the monkey mediodorsal thalamus: Location of projection neurons and ultrastructural characteristics of axon terminals. Melchitzky DS; Erickson SL; Lewis DA Neuroscience; 2006 Dec; 143(4):1021-30. PubMed ID: 17029800 [TBL] [Abstract][Full Text] [Related]
36. Synaptic relationships between induced neuropeptide Y-like immunoreactive terminals and cuneothalamic projection neurons in the rat cuneate nucleus following median nerve transection. Yeh JH; Lue JH; Wang HY; Huang CT; Tsai YJ J Chem Neuroanat; 2008 Sep; 36(1):27-32. PubMed ID: 18602245 [TBL] [Abstract][Full Text] [Related]
37. Alpha-synuclein and Parkinson's disease: a proteomic view. Fasano M; Lopiano L Expert Rev Proteomics; 2008 Apr; 5(2):239-48. PubMed ID: 18466054 [TBL] [Abstract][Full Text] [Related]
38. Localization of alpha-synuclein to mitochondria within midbrain of mice. Li WW; Yang R; Guo JC; Ren HM; Zha XL; Cheng JS; Cai DF Neuroreport; 2007 Oct; 18(15):1543-6. PubMed ID: 17885598 [TBL] [Abstract][Full Text] [Related]
39. Functional protein kinase arrays reveal inhibition of p-21-activated kinase 4 by alpha-synuclein oligomers. Danzer KM; Schnack C; Sutcliffe A; Hengerer B; Gillardon F J Neurochem; 2007 Dec; 103(6):2401-7. PubMed ID: 17883396 [TBL] [Abstract][Full Text] [Related]